24
Participants
Start Date
February 9, 2021
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2025
ORIN1001
Oral tablet - ORIN1001
Placebo
Oral tablet - placebo
Duke University Hospital, Durham
Mayo Clinic Hospital, Jacksonville
Avanza Medical Research, Pensacola
Coastal Pulmonary and Critical Care, St. Petersburg
St. Francis Sleep, Allergy & Lung Institute, Clearwater
University of Cincinnati, Cincinnati
University of Iowa Hospital, Iowa City
Loyola University Medical Center, Maywood
Hannibal Clinic, Hannibal
Infinity Medical Research, North Dartmouth
Dartmouth Hitchcock Medical Center, Lebanon
Lead Sponsor
Vanderbilt University
OTHER
Orinove, Inc.
INDUSTRY